Publications

JOSÉ MARÍA AGUADO GARCÍA publications

363 results

2026

  1. Cytomegalovirus infection in patients receiving bispecific antibodies for multiple myeloma and B-cell malignancies: a single-center cohort and meta-analysis

    Frontiers in Oncology, Vol. 16

  2. Diagnostic Performance of Two Different Techniques to Quantify CMV-Specific Cell-Mediated Immunity in Intermediate-Risk Seropositive Kidney Transplant Recipients

    Transplant Infectious Disease, Vol. 28, Núm. 1

  3. Epidemiology and Risk Factors for Infection in Multiple Myeloma Patients Treated With Bispecific Antibodies

    Open Forum Infectious Diseases, Vol. 13, Núm. 8

  4. Evaluation of an Immune-guided Prevention Strategy Against CMV Among Intermediate-risk Kidney Transplant Recipients: A Quasi-experimental Study

    Transplantation, Vol. 110, Núm. 6, pp. e1265-e1275

  5. Experience with isavuconazole in lung transplant recipients with Aspergillus isolation in respiratory tract specimens: A multicenter, observational study

    JHLT Open, Vol. 11

  6. False-positive results of the turbidimetric β-D-glucan assay in patients with bacteremia

    Diagnostic Microbiology and Infectious Disease, Vol. 114, Núm. 3

  7. Genetic patterns related to von Willebrand factor: implications on the need for mechanical ventilation, severity, and death in COVID-19

    Frontiers in Medicine, Vol. 12

  8. How can we optimize the diagnostic and therapeutic approach of urinary tract infection? Expert opinion-based recommendations

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 44, Núm. 1

  9. Implementation of a novel aseptic insertion device for peripheral venous catheters: safety, performance, and nurse satisfaction

    Journal of Hospital Infection, Vol. 168, pp. 88-96

  10. Infectious Complications in Living Donation Versus Donation After Brain Death Kidney Transplantation

    Transplant Infectious Disease

  11. Olorofim in combination with azole antifungals: results from the Phase 2 salvage therapy study

    Journal of Antimicrobial Chemotherapy, Vol. 81, Núm. 4

  12. Randomized double-blind clinical trial evaluating the effectiveness and safety of secondary prophylaxis with oral vancomycin versus placebo in the prevention of recurrence of clostridioides difficile infection in patients receiving systemic antibiotic therapy (PREVAN trial)

    JAC-Antimicrobial Resistance, Vol. 8, Núm. 2

  13. Real-life experience with maribavir for the treatment of cytomegalovirus infection in solid organ transplant recipients

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 44, Núm. 5

  14. Rezafungin for Salvage or Consolidation Therapy of Invasive Fungal Disease: Experience in Real-World Clinical Practice

    Mycoses, Vol. 69, Núm. 2

  15. Solid Organ Transplant Recipients With Clostridioides difficile Infection Had Lower Fecal Calprotectin and Lactoferrin Levels Compared to Immunocompetent Patients: Implications for Biomarker Interpretation

    Transplant Infectious Disease

  16. Tuberculosis in lung and heart transplant recipients

    JHLT Open, Vol. 11

2025

  1. Breakthrough Invasive Mold Infections in Hematologic Cases: Relevance of the Host's Factors

    Open Forum Infectious Diseases, Vol. 12, Núm. 2

  2. CTLA4 Single-Nucleotide Polymorphisms Influence the Risk of HSV and VZV Infection in Kidney Transplant Recipients: A Prospective Cohort Study

    Transplant International, Vol. 38

  3. Challenges and controversies of urinary tract infection treatment in kidney transplant recipients

    Expert Review of Anti-Infective Therapy, Vol. 23, Núm. 10, pp. 933-950

  4. Fármacos antifúngicos

    Velázquez, farmacología básica y clínica (Editorial Médica Panamericana), pp. 957-974